About us

Rosetta has made 50+ venture investments through direct secondary transactions over 20+ years and has vast experience of completing transactions in an efficient manner.
As a secondary investor, we provide flexible liquidity solutions for other investors or corporations that wish to divest some or all of their investment assets or to access additional capital and resource to optimise investment outcomes.
We bring new capital to participate in follow-on financings and help support the company through value-adding inflection points.
We have an exceptional track record over 21 years:
Global investment horizon
funds
raised and deployed across the life sciences and medical device sectors
million
in historical commitments

Find out more
Case studies
We have an experienced investment team that has a long history of completing secondary transactions with European and North American healthcare investors to acquire equity positions in portfolio companies.